We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Levitra may not rise to expectations

20 August 2003 By Robert Cyran

The US has approved Levitra, a rival to blockbuster Viagra. The companies are relying on it to replace sales lost to generics competition. With nothing else in the pipeline, Bayer needs the drug to succeed.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)